The onset of type 2 diabetes: proposal for a multi-scale model
- PMID: 24176906
- PMCID: PMC3841357
- DOI: 10.2196/resprot.2854
The onset of type 2 diabetes: proposal for a multi-scale model
Abstract
Background: Type 2 diabetes mellitus (T2D) is a common age-related disease, and is a major health concern, particularly in developed countries where the population is aging, including Europe. The multi-scale immune system simulator for the onset of type 2 diabetes (MISSION-T2D) is a European Union-funded project that aims to develop and validate an integrated, multilevel, and patient-specific model, incorporating genetic, metabolic, and nutritional data for the simulation and prediction of metabolic and inflammatory processes in the onset and progression of T2D. The project will ultimately provide a tool for diagnosis and clinical decision making that can estimate the risk of developing T2D and predict its progression in response to possible therapies. Recent data showed that T2D and its complications, specifically in the heart, kidney, retina, and feet, should be considered a systemic disease that is sustained by a pervasive, metabolically-driven state of inflammation. Accordingly, there is an urgent need (1) to understand the complex mechanisms underpinning the onset of this disease, and (2) to identify early patient-specific diagnostic parameters and related inflammatory indicators.
Objective: We aim to accomplish this mission by setting up a multi-scale model to study the systemic interactions of the biological mechanisms involved in response to a variety of nutritional and metabolic stimuli and stressors.
Methods: Specifically, we will be studying the biological mechanisms of immunological/inflammatory processes, energy intake/expenditure ratio, and cell cycle rate. The overall architecture of the model will exploit an already established immune system simulator as well as several discrete and continuous mathematical methods for modeling of the processes critically involved in the onset and progression of T2D. We aim to validate the predictions of our models using actual biological and clinical data.
Results: This study was initiated in March 2013 and is expected to be completed by February 2016.
Conclusions: MISSION-T2D aims to pave the way for translating validated multilevel immune-metabolic models into the clinical setting of T2D. This approach will eventually generate predictive biomarkers for this disease from the integration of clinical data with metabolic, nutritional, immune/inflammatory, genetic, and gut microbiota profiles. Eventually, it should prove possible to translate these into cost-effective and mobile-based diagnostic tools.
Keywords: computational biology; data integration; metabolism; metaflammation; multiscale modeling; physical activity; simulation; type 2 diabetes.
Conflict of interest statement
Conflicts of Interest: None declared.
Figures







Similar articles
-
Amino acid and lipid metabolism in post-gestational diabetes and progression to type 2 diabetes: A metabolic profiling study.PLoS Med. 2020 May 20;17(5):e1003112. doi: 10.1371/journal.pmed.1003112. eCollection 2020 May. PLoS Med. 2020. PMID: 32433647 Free PMC article.
-
Diabetes and branched-chain amino acids: What is the link?J Diabetes. 2018 May;10(5):350-352. doi: 10.1111/1753-0407.12645. Epub 2018 Feb 13. J Diabetes. 2018. PMID: 29369529
-
Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.Med J Aust. 2019 Nov;211 Suppl 9:S3-S46. doi: 10.5694/mja2.50383. Med J Aust. 2019. PMID: 31679171
-
Role of the gut microbiota in type 2 diabetes and related diseases.Metabolism. 2021 Apr;117:154712. doi: 10.1016/j.metabol.2021.154712. Epub 2021 Jan 23. Metabolism. 2021. PMID: 33497712 Review.
-
Data-driven modeling and prediction of blood glucose dynamics: Machine learning applications in type 1 diabetes.Artif Intell Med. 2019 Jul;98:109-134. doi: 10.1016/j.artmed.2019.07.007. Epub 2019 Jul 26. Artif Intell Med. 2019. PMID: 31383477 Review.
Cited by
-
Effects of walking on low-grade inflammation and their implications for Type 2 Diabetes.Prev Med Rep. 2015 Jun 16;2:538-47. doi: 10.1016/j.pmedr.2015.06.012. eCollection 2015. Prev Med Rep. 2015. PMID: 26844115 Free PMC article. Review.
-
Personalizing physical exercise in a computational model of fuel homeostasis.PLoS Comput Biol. 2018 Apr 26;14(4):e1006073. doi: 10.1371/journal.pcbi.1006073. eCollection 2018 Apr. PLoS Comput Biol. 2018. PMID: 29698395 Free PMC article.
-
Modeling biology spanning different scales: an open challenge.Biomed Res Int. 2014;2014:902545. doi: 10.1155/2014/902545. Epub 2014 Jul 17. Biomed Res Int. 2014. PMID: 25143952 Free PMC article. Review.
-
Mesenchymal stem cells ameliorate β cell dysfunction of human type 2 diabetic islets by reversing β cell dedifferentiation.EBioMedicine. 2020 Jan;51:102615. doi: 10.1016/j.ebiom.2019.102615. Epub 2020 Jan 6. EBioMedicine. 2020. PMID: 31918404 Free PMC article.
-
A closed-loop multi-level model of glucose homeostasis.PLoS One. 2018 Feb 8;13(2):e0190627. doi: 10.1371/journal.pone.0190627. eCollection 2018. PLoS One. 2018. PMID: 29420588 Free PMC article.
References
-
- World Health Organization. [2013-06-14]. Diabetes facts and figures http://who.int/mediacentre/factsheets/fs312/en/index.html.
-
- Coveney PV, Diaz V, Hunter P, Kohl P, Viceconti M. The virtual physiological human. Interface Focus. 2011 Mar 31;1(3):281–285. doi: 10.1098/rsfs.2011.0020. - DOI
-
- Donath MY, Böni-Schnetzler M, Ellingsgaard H, Ehses JA. Islet inflammation impairs the pancreatic beta-cell in type 2 diabetes. Physiology (Bethesda) 2009 Dec;24:325–31. doi: 10.1152/physiol.00032.2009. http://nips.physiology.org/cgi/pmidlookup?view=long&pmid=19996363 - DOI - PubMed
-
- Kahn BB. Type 2 diabetes: when insulin secretion fails to compensate for insulin resistance. Cell. 1998 Mar 6;92(5):593–6. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical